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Edited by Stuart FergusonAbstract The identity of the acid/base catalyst of the Family 35
b-galactosidases from Xanthomonas manihotis (BgaX) has been
conﬁrmed as Glu184 by kinetic analysis of mutants modiﬁed at
that position. The Glu184Ala mutant of BgaX is shown to func-
tion as an eﬃcient thioglycoligase, which synthesises thiogalac-
tosides with linkages to the 3 and 4 positions of glucosides and
galactosides in high (>80%) yields. Kinetic analysis of the thio-
glycoligase reveals glycosyl donor Km values of 1.5–21 lM and
glycosyl acceptor Km values from 180 to 500 lM. This mutant
should be a valuable catalyst for the synthesis of metabolically
stable analogues of this important glycosidic linkage.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Thioglycosides1. Introduction
Due to the important roles of oligosaccharides and glycans
in many biological processes in cells [1], the naturally occurring
oligosaccharides and their analogues are of particular interest
as carbohydrate-based therapeutics [2]. However, the applica-
tion of carbohydrate-based therapeutics may be limited, in
some cases, as a consequence of their susceptibility to enzy-
matic hydrolysis by endogenous glycosidases [3]. One strategy
towards circumventing this problem is to replace the intergly-
cosidic oxygen atom with a sulfur atom to give sulfur-linked
oligosaccharides [4,5]. Glycosidase-resistant thioglycoside ana-
logues of the original oligosaccharides are therefore attractive
candidates as potential therapeutics, as stable antigens, and as
biochemical probes due to their much lower rates of chemicalAbbreviations: DNP, 2,4-dinitrophenyl; PNP, 4-nitrophenyl; BgaX, b-
galactosidase from Xanthomonas manihotis; Abg, b-glucosidase from
Agrobacterium sp.; GH, glycoside hydrolase; TLC, thin layer chroma-
tography; NMR, nuclear magnetic resonance; ESI, electrospray ioni-
zation; DNPGal, 3,4-dinitrophenyl b-D-galactopyranoside; PNPGal,
4-nitrophenyl b-D-galactopyranoside; PNP4SGlc, 4-nitrophenyl 4-de-
oxy-4-thio-b-D-glucopyranoside; PNP3SGlc, 4-nitrophenyl 3-deoxy-3-
thio-b-D-glucopyranoside; PNP6SGlc, 4-nitrophenyl 6-deoxy-6-thio-b-
D-glucopyranoside; PNP4SGal, 4-nitrophenyl 4-deoxy-4-thio-b-D-gal-
actopyranoside; PNP3SGal, 4-nitrophenyl 3-deoxy-3-thio-b-D-galac-
topyranoside
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doi:10.1016/j.febslet.2006.06.095and enzymatic hydrolysis and their similar conformations to
those of their natural O-linked counterparts [6]. A number of
successful chemical syntheses of thio-oligosaccharides have
been reported [7–9], but control of stereochemistry remains
challenging. Recently, enzymatic strategies have been reported
using mutant forms of glycosidases: thioglycoligases [10] and
thioglycosynthases [11] as well as, but less eﬃciently to date,
glycosyltransferases [12].
Thioglycoligases are mutant enzymes derived from retaining
glycosidases in which the acid/base carboxylic acid residue has
been replaced by an amino acid that has no negative charge
(Fig. 1). When these mutants are incubated with substrates
bearing a good leaving group, such as dinitrophenol (DNP)
or ﬂuoride, they relatively rapidly form a covalent glycosyl-en-
zyme intermediate because they do not need assistance from
the acid catalyst. Since the mutants have no general base cat-
alyst, the rates of transglycosylation to normal acceptors such
as water and hydroxyl-containing sugars are extremely low.
However, transfer occurs eﬃciently to acceptors bearing a suit-
ably-positioned thiol since the thiol group is much more nucle-
ophilic and requires no general base catalytic assistance. The
thioglycoligase strategy has been applied recently in the syn-
thesis of thio-linked inhibitors for use as structural probes
[13] and in the modiﬁcation of glycans on the surface of a
model glycoprotein [14].
A class of glycosidic linkages that is of particular interest,
but which has not yet addressed by glycosynthase [15] or thio-
glycoligase strategies, is that of the Gal-b-1,3-GlcNAc and
Gal-b-1,3-GalNAc linkages found in gangliosides and glyco-
proteins. While b-galactosidases are found in glycoside hydro-
lase (GH) Families 1, 2, 35, and 42, only those in Family 35
have speciﬁcities directed toward Gal-b-1,3-linkages. This fam-
ily contains the human lysosomal b-galactosidases responsible
for catabolism of such glycoconjugates and deﬁciencies in this
enzyme arising from mutations lead to the neurological disor-
ders GM1-gangliosidosis and Morquio B. syndrome [16].
Through the use of mechanism-based inactivators that result
in trapping of a glycosyl-enzyme intermediate, the catalytic
nucleophile of this enzyme was identiﬁed as Glu268 [17].
Labeling of the equivalent residue, Glu260, in the homologous
bacterial enzyme from Xanthomonas manihotis conﬁrmed the
nucleophilic role of this residue [18]. No information was avail-
able on the identity of the acid/base catalyst until the relatively
recent solution of the three-dimensional structure of the Fam-
ily 35 b-galactosidase from Penicillium sp. by X-ray crystallog-
raphy [19]. On the basis of a product complex with galactose,blished by Elsevier B.V. All rights reserved.
Fig. 1. Mechanisms of transglycosylation by retaining galactosidases (A) and thiogalactoligases (B).
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However, there has been no conﬁrmation of this proposed role
by kinetic analysis of mutants. The b-galactosidase from X.
manihotis (BgaX) is a good test system with which to conﬁrm
this assignment and to assess the potential for generation of
thioglycoligases of the desired speciﬁcity. The wild type en-
zyme has been shown previously to synthesise Gal-b-1,3-Glc-
NAc linkages via transglycosylation, albeit in rather low
yields [20,21], though attempts to generate a glycosynthase
from BgaX have been unsuccessful to date (Blanchard, J.
and Withers, S.G., unpublished data).
Herein, we describe the conﬁrmation of Glu184 as the acid/
base catalyst in BgaX, analogous to Glu200 in Penicillium sp.
b-galactosidase, by azide rescue analysis with the Glu184Ala
mutant. We demonstrate that this mutant functions as an eﬃ-
cient thioglycoligase capable of synthesizing both b-1,3- and b-
1,4-thioglycosidic linkages, depending on the position of the
thiol-group in the acceptor. Detailed kinetic analyses revealed
low Km values for both glycosyl donors and thio-sugar accep-
tors, and substantial preference for transfer to the 3-position of
gluco-conﬁgured acceptors.2. Materials and methods
2.1. Materials and general analysis
All chemicals were obtained from the Sigma Chemical Co. unless
otherwise speciﬁed. Pwo polymerase was purchased from Roche and
restriction enzymes from Fermentas (Germany). 4-Nitrophenyl 4-
deoxy-4-thio-b-D-glucopyranoside (PNP4SGlc), and 4-nitrophenyl 4-
deoxy-4-thio-b-D-galactopyranoside (PNP4SGal) were synthesized
according to literature procedures [10]. The synthetic details of the
preparation of 4-nitrophenyl 6-deoxy-6-thio-b-D-glucopyranoside
(PNP6SGlc), 4-nitrophenyl 3-deoxy-3-thio-b-D-glucopyranoside
(PNP3SGlc), and 4-nitrophenyl 3-deoxy-3-thio-b-D-galactopyranoside
(PNP3SGal) will be published elsewhere. All 1H and 13C nuclear mag-
netic resonance (NMR) spectra were recorded at 400 MHz using a
Bruker AV-400 spectrometer. Mass spectra of small molecules were re-
corded using a PE-Sciex API 300 triple quadrupole mass spectrometer
(Sciex, Thornhill, Ont., Canada) equipped with an electrospray ioniza-
tion (ESI) ion source. Thin layer chromatography (TLC) was per-
formed on aluminum-backed sheets of silica gel 60F254 (Merck) of
thickness 0.2 mm. The plates were visualized using UV light
(254 nm) and/or by exposure to 10% sulfuric acid in methanol followed
by charring.2.2. Construction of BgaX-E184A and E184Q mutants
The mutations of the acid/base residue of BgaX were introduced
using a mega primer PCR method. The gene encoding the 6x histidine
tagged BgaX obtained by digestion of pTUG10N18/b-Gal [18] with
NcoI and HindIII was subcloned into a pET28a vector (Novagen).
The resulting plasmid, namely pET28BgaX(His)6, was used as the
template for the mutation of BgaX. The front ends of the genes for
BgaX-E184A and BgaX-E184Q were ﬁrst ampliﬁed using a T7 pro-
moter primer and the following BgaX-E184A-rev primer (5 0-GTCGG-
CGTAGGAGCCGTAGGCGTTCTCGAC-3 0) and BgaX-E184Q-rev
primer (5 0-GTCGGCGTAGGAGCCGTACTGGTTCTCGAC-3 0).
The PCR products were puriﬁed using a QIAquick Gel Extraction
Kit (Qiagen) and then used as megaprimers to obtain the full length
genes with the T7 terminator primer. The ﬁnal PCR products were di-
gested with NcoI and HindIII, then extracted from the agarose gel
using a QIAquick Gel Extraction Kit and ligated with pET28a that
had been digested with the corresponding restriction enzymes. The
resulting plasmids were designated pET28BgaX-E184A(His)6 and
pET28BgaX-E184Q(His)6, respectively.
2.3. Expression and puriﬁcation of BgaX-E184A mutant
The plasmids containing genes for BgaX mutants were transformed
into Escherichia coli, and the recombinant E. coli was cultured for 6 h
at 37 C in Luria–Bertani medium containing 20 lg/mL of kanamycin,
followed by overnight IPTG induction (0.2 mM) at 30 C. The crude
enzyme solutions were prepared by lysis of the harvested cells using
BugbusterTM solution (Novagen). The crude enzyme solutions were
centrifuged at 10000 · g for 30 min and the supernatants were loaded
onto a HisTrapTM FF column (Amersham Biosciences). BgaX mutants
were eluted using a step-gradient of 10 mMﬁ 20 mMﬁ 250 mM
imidazole in 20 mM Tris–HCl buﬀer (pH 8.0) containing 500 mM
NaCl. For further puriﬁcation, ammonium sulfate was added directly
to the fractions containing BgaX mutants until the ﬁnal concentration
of ammonium sulfate was 2 M, then the enzyme solutions were sub-
jected to hydrophobic interaction chromatography using a HiTrapTM
Phenyl HP column (Amersham Biosciences). BgaX mutants were
eluted with a linear gradient of 2 Mﬁ 0 M ammonium sulfate in
20 mM Tris–HCl buﬀer (pH 8.0). The pure enzyme fractions were
combined, dialyzed, and then concentrated using an Amicon Ultra-4
ﬁlter unit (10000 Da, cut-oﬀ, Millipore). Concentrations of enzyme
solution were quantiﬁed by the Bradford method using bovine serum
albumin as a standard [22].
2.4. Hydrolysis and thioglycosylation kinetics
All kinetic studies were performed at 30 C in pH 7.0, 100 mM phos-
phate buﬀer. Twenty microliters of BgaX-E184A was added to 100 lL
of buﬀer containing either 3,4-dinitrophenyl b-D-galactopyranoside
(DNPGal) or 4-nitrophenyl b-D-galactopyranoside (PNPGal) as do-
nors and thio-sugar acceptors for transglycosylation. Hydrolysis of
Fig. 2. Eﬀect of added azide nucleophile on cleavage of DNPGal by
BgaX-E184A. Enzyme activity was measured at increasing concentra-
tions of azide (0–130 mM). Vazide and V0 represent the initial velocities
in the presence and absence of azide, respectively.
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tors. Rescue of the glycosidic bond cleaving activity of BgaX-E184A
was performed in the presence of various concentrations of azide as
a nucleophile at a ﬁxed concentration of DNPGal (0.1 mM). The re-
lease of the nitrophenols was monitored at 400 nm using a microplate
reader (SPECTRAMax plus, Molecular Devices Corporation). The
values of Km and kcat, which are strictly apparent Km and kcat since
they are determined at a ﬁxed, non-saturating co-substrate concentra-
tion, were determined by ﬁtting the initial velocity curves to the
Michaelis–Menten equation using non-linear regression with the pro-
gram GraFit [23].
2.5. Preparative thioglycoligase reactions and isolation of products
All thioglycoligase reactions were carried out at room temperature
in 3–5 mL of 100 mM sodium phosphate buﬀer, pH 7.0. Thiosugar
acceptors (9 mg) were dissolved in 200 lL of DMF, and then an
equal amount of DNPGal was added as donor. BgaX-E184A
(0.3 mg) was added and the mixture then incubated at 25 C. Reactions
were monitored by TLC. Upon completion, the reaction mixtures were
subjected to a C18 SEP PAK cartridge (Waters) to remove free sugars,
enzyme, and salts, and then the solvent was evaporated under reduced
pressure. Transfer products were puriﬁed by ﬂash chromatography
(EtOAc/MeOH/H2O = 17:2:1ﬁ 7:2:1) using Silica Gel 60 (230 ± 400
mesh) and reaction yields were determined by weighing the isolated
products. The puriﬁed compounds were acetylated in pyridine and
Ac2O. The acetylated thio-disaccharides, puriﬁed using ﬂash chroma-
tography (EtOAc/hexanes = 1:1), were subjected to electrospray ioni-
zation mass spectrometry and 1H and 13C NMR spectroscopy.3. Results and discussion
In order to conﬁrm Glu184 as the acid/base catalyst in BgaX
amutant was made in which an alanine, a standard substitution
to remove the charge and acid/base properties, was introduced
at the position of Glu184 in BgaX. Michaelis–Menten parame-
ters for hydrolysis of DNPGal and PNPGal (Table 1) were
completely consistent with a role of Glu184 as acid/base cata-
lyst, as follows. The observation of very similar kcat values
for two substrates of very diﬀerent reactivity, DNPGal and
PNPGal, with BgaX-E184A (2.1 and 2.6 min1) strongly sug-
gested that the deglycosylation step (which would be indepen-
dent of substrate leaving group ability) is rate-limiting in each
case. In support of this conclusion are the very low Km values,
particularly that of around 100 nM for DNPGal with BgaX-
E184A. Such a low value suggests accumulation of the interme-
diate, as would be expected if deglycosylation is rate-limiting.
Importantly, kcat/Km values, which reﬂect the ﬁrst irreversible
step (glycosylation), diﬀer by 25-fold for the two substrates,
as expected based upon their diﬀerent reactivity. A second test
of the role of Glu184 as acid/base catalyst is rescue of the activ-
ity of BgaX-E184A by an added nucleophile, such as azide
anion. Generally, when reacted with activated substrates, theTable 1
Kinetic parameters for hydrolysis by BgaX wild type and mutant
Enzyme Substrate kcat (min
1) Km (lM) kcat/Km
(min1 mM1)
WTa PNPGal 2140 50 42800
E184A PNPGal 2.1 2.0 1050
E184A DNPGal 2.6 0.08b 32500b
aData from reference [17]. Errors in kinetic parameters are less than
10% for Km and 5% for kcat.
bErrors on these parameters are ±50% due to the low enzyme con-
centration needed for the Km determination in order to ensure
Michaelian behaviour.glycosyl-enzyme intermediate of retaining glycosidase mutants
modiﬁed at the acid/base catalyst accumulates. However, upon
introduction of azide or equivalent nucleophiles rapid turn-
over of the intermediate occurs via nucleophilic attack of the
added external nucleophiles. Rescue of activity of the mutants
thereby occurs with formation of a glycosyl azide product [24–
26]. As expected, increasing concentrations of azide resulted in
enhanced reaction rates of cleavage of DNPGal by BgaX-
E184A (Fig. 2). These results, therefore, suggest that Glu184
of BgaX plays the role of the acid/base catalyst.
Based upon previous experience with Agrobacterium sp. b-
glucosidase (Abg) thioglycoligases [27], a second acid/base mu-
tant was also prepared: Glu184Gln. As a fast test of potential
thioglycoligase activity of BgaX-E184A and BgaX-E184Q a
series of small scale reactions was set up using DNPGal as do-
nor and various PNP glycosides with thiol groups at positions
3, 4 and 6 as acceptors. After 12 h incubation, no useful
amounts of thio-disaccharide product were seen with BgaX-
E184Q, whereas a single product was clearly formed by
BgaX-E184A in each reaction with 4-nitrophenyl 3-deoxy-3-
thio-b-D-galactopyranoside (PNP3SGal), PNP4SGlc, and
PNP3SGlc. No transfer was seen, however, to the axial
thiol-group in PNP4SGal or the 6-thiol-group in PNP6SGlc,
nor was any transfer observed to the hydroxyl group of DNP-
Gal. While the fact that BgaX-E184Q does not function as a
thioglycoligase diﬀerentiates it from Abg, in fact the same sit-
uation has been observed in the a-xylosidase from E. coli and
the b-mannosidase from Cellulomonas ﬁmi (Kim, Y. W., Jahn,
M., Mullegger, J. and Withers, S. G., unpublished data).
To further investigate the catalytic properties of BgaX-
E184A as a thioglycoligase, apparent kinetic parameters were
determined for both DNPGal and PNPGal as donors in the
presence of various thio-sugar acceptors (Table 2). These stud-
ies were considerably simpliﬁed by the fact that the products of
thioglycoligase action are not acceptors for further transfer
since they contain no free thiols, and by the ﬁnding that simple
hydrolysis is much slower than transglycosylation to the thio-
sugars. Studies were ﬁrst carried out at a ﬁxed concentration of
a thio-sugar acceptor (PNP3SGlc, 0.8 mM) using PNPGal or
DNPGal as donors at a range of concentrations. The apparent
kcat values for DNPGal and PNPGal were enhanced in the
presence of the thiosugar acceptor by 43.3-fold and 8.5-fold,
respectively, compared to those for simple hydrolysis of each
Table 2















PNPGal PNP3SGlcb 17.7 21 843
DNPGal PNP3SGlcb 115 5.9 19491
DNPGal PNP3SGalb 25.2 2.6 9692
DNPGal PNP4SGlcb 35.8 1.5 23866
PNP3SGlc DNPGalc 221 490 451
PNP3SGal DNPGalc 22.5 180 125
PNP4SGlc DNPGalc 34.5 320 108
Errors in kinetic parameters in this table are 10–14% for Km and 2–5%
for kcat.
aValues are apparent parameters at the co-substrate concentration
indicated.
bConcentrations of thio-sugars were ﬁxed at 0.8 mM.
cConcentrations of DNPGal was ﬁxed at 0.1 mM.
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for the thioglycoligase reactions means that, in contrast to
what was seen for the hydrolytic reaction, the rate-limiting step
has now shifted to the glycosylation step, at least for PNPGal.
This is, of course, consistent with the dramatic elevation of
the rates of deglycosylation by the thio-sugar acceptors. TheFig. 3. Kinetics of transglycosylation catalysed by BgaX-E184A. (A) Depend
of PNP3SGlc (h), PNP3SGal (d), and PNP4SGlc (h). (B) Dependence of ra
(h) at a ﬁxed (0.1 mM) concentration of DNPGal. The error ranges for dat
Table 3



















OHhigher glycosyl donor Km values (apparent) for the thioglyco-
ligase reactions compared to those seen for hydrolysis also
support this interpretation.
Acceptor speciﬁcities of BgaX-E184A were then investigated
by determining kinetic parameters for DNPGal at a ﬁxed con-
centration (0.8 mM) of each thio-sugar acceptor (PNP3SGal,
PNP3SGlc, and PNP4SGlc). Given the catalytic properties
of the wild type enzyme we expected that b-1,3 thioglycosidic
linkages would be formed more eﬃciently than b-1,4 linkages
by BgaX-E184A and indeed PNP3SGlc was the best acceptor
tested. Perhaps surprisingly, however, the next best acceptor
was PNP4SGlc rather than PNP3SGal (Fig. 3A, Table 2). This
outcome is possibly the result of either disfavored binding of a
galactoside in the +1 subsite of this enzyme or inhibition of the
enzyme by PNP3SGal. Hence, we investigated the reactions
with varying concentrations of the thiosugar acceptors at a
ﬁxed concentration of DNPGal (0.1 mM). BgaX-E184A
showed standard saturation kinetic behaviour for all acceptors
(Fig. 3B) and the apparent values of kcat for these thiosugar
acceptors showed the same tendencies as those seen in the
experiments above (Table 2). These kinetic data for BgaX-
E184A with various acceptors suggest that glucosides are sub-
stantially preferred as acceptors over galactosides with thisence of rate on DNPGal concentration at ﬁxed (0.8 mM) concentration
te on concentrations of PNP3SGlc (s), PNP3SGal (d), and PNP4SGlc
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ous investigations of the acceptor speciﬁcity of the wild type
BgaX wherein galactosides were shown not to function as reac-
tivators of the 2-deoxy-2-ﬂuorogalactosyl enzyme via transgly-
cosylation [28].
Preparative scale reactions were carried out using DNPGal as
a donor to various thio-sugar acceptors. An equimolar ratio of
donor to acceptor was enough to obtain the thio-disaccharides
in more than 80% yields (Table 3). As expected based on mea-
sured kinetic parameters for the thioglycoligase reactions, the
reactions with PNP3SGlc were accomplished very eﬃciently
(1 h incubation, 80% yield), while reactions with either
PNP4SGlc or PNP3SGal needed longer incubation times (6 h
and 10h incubation, respectively) to complete the consumption
of the thio-sugar acceptors. ESI-mass spectrometry and NMR
analyses of the acetylated products conﬁrmed the structures
shown in Table 3.
In conclusion, the catalytic acid/base of GH35 enzyme has
been conﬁrmed, for the ﬁrst time, by kinetic analysis with a
bacterial b-galactosidase (BgaX) mutant modiﬁed at the
residue corresponding to the previously proposed acid/base
catalyst based on the three-dimensional structure of b-galacto-
sidase from Penicillium sp. The substitution of the acid/base
catalyst with alanine allows synthesis of both b-1,3 and b-
1,4-linked thiodisaccharides through the thioglycoligase mech-
anism. The BgaX thioglycoligase is therefore a valuable tool
for the synthesis of thio-linked analogues of oligosaccharides
found in many surface antigens.
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